Larvol Delta - Augmented-Antitumor-Activity-for-Novel-Dual-PI3KBDR4-Inhibitors-SF2523-and-SF1126-in-Ewing-Sarcoma

SF2523 - SignalRx

SF1126 - SignalRx

http://www.ncbi.nlm.nih.gov/pubmed/33480647

Jan 23, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next